The Effect of Inflammatory Bowel Disease and Irritable Bowel Syndrome on Pravastatin Oral Bioavailability: In vivo and in silico evaluation using bottom-up wbPBPK modeling
Crossref DOI link: https://doi.org/10.1208/s12249-024-02803-z
Published Online: 2024-04-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Alsmadi, Motasem M. https://orcid.org/0000-0003-0640-8085
Abudaqqa, Alla A.
Idkaidek, Nasir
Qinna, Nidal A.
Al-Ghazawi, Ahmad
Text and Data Mining valid from 2024-04-11
Version of Record valid from 2024-04-11
Article History
Received: 8 January 2024
Accepted: 1 April 2024
First Online: 11 April 2024
Declarations
:
: None declared.